-
Mashup Score: 0Duchenne gene therapy from Solid Biosciences produces promising results in early study - 4 day(s) ago
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1Duchenne gene therapy from Solid Biosciences produces promising results in early study - 4 day(s) ago
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Solid's Duchenne gene therapy shows early promise https://t.co/O3QFEKKZgn
-
-
Mashup Score: 2
Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, outside the U.S.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, outside the U.S. https://t.co/M3UcWQQxOp
-
-
Mashup Score: 4
Biogen and Stoke Therapeutics have signed a deal to co-develop and sell Stoke’s experimental drug for Dravet syndrome, outside the U.S.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Biogen partners with Stoke Therapeutics on drug for Dravet syndrome https://t.co/CZgFHzdPSs
-
-
Mashup Score: 3
XRHealth is acquiring RealizedCare, a company that couples immersive experiences with coaches for chronic pain management.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
XRHealth is acquiring RealizedCare, a company that couples immersive experiences with coaches for chronic pain management. https://t.co/56fzmSWJyo
-
-
Mashup Score: 0The lasting human impact of Trump funding freeze: An 86-year-old's ride to dialysis now feels tenuous - 4 day(s) ago
The uncertainty around the spending freeze was an epiphany for some, a realization of how omnipresent government services are
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
The uncertainty around the spending freeze was an epiphany for some, a realization of how omnipresent government services are https://t.co/t8RUUIfsrK
-
-
Mashup Score: 4What my sister’s life and death taught me about the NIH - 4 day(s) ago
“A decade ago this past June, my sister died at the National Institutes of Health. I still have faith in them, and I hope that the country does, too,” writes Ariel Reinish.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
“A decade ago this past June, my sister died at the National Institutes of Health. I still have faith in them, and I hope that the country does, too,” writes… https://t.co/BptsqFrKMf
-
-
Mashup Score: 9
Layoffs at the FDA appear to have hit the AI and digital health staff particularly hard. It also has a strained relationship with Musk’s company Neuralink.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
#News: FDA cuts hit AI division, even as Trump invests in the technology https://t.co/d76mA0lKzP
-
-
Mashup Score: 2Biotech is in a dark place - 4 day(s) ago
Biotech and drug stocks, collectively, are down an average of 16% over the past three months. The closely watched XBI index is down 19% in the same time period.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
The column expands from a look at stocks to trenchant takes on the future of the FDA and NIH. Read it here: https://t.co/UKkosOISND
-
-
Mashup Score: 7Drug inspectors, AI experts, maternal health workers: Trump’s health agency cuts are far-reaching - 4 day(s) ago
ead this email immediately” That was the subject line of emails that landed in the inboxes of thousands of workers at federal health agencies across the
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet-
Drug inspectors, AI experts, maternal health workers: Trump’s health agency cuts are far-reaching https://t.co/UazATn26Oj
-
Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an early sign of promise https://t.co/vVUMLjlP2j